Zeus Names New Chief Executive Officer
Werte in diesem Artikel
- Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO
- O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership
- O'Brien currently serves as Worldwide President of BD Peripheral Intervention
ORANGEBURG, S.C., March 14, 2024 /PRNewswire/ -- Zeus, the world's leading polymer extrusion and catheter design manufacturer, is excited to announce the appointment of Padraic "Paddy" O'Brien as Chief Executive Officer, effective April 1, 2024. O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership.

O'Brien is currently Worldwide President of BD Peripheral Intervention at Becton, Dickinson, and Company (NYSE: BDX), a medical technology company focused on advancing clinical therapy for patients and clinical process for healthcare providers.
Before that, he held various leadership positions within BD, where he developed an extensive and consistent track record of delivering durable, sustainable growth while creating a winning culture. From 2001-2016, he held a series of ascending management positions within Bard until BD acquired the company in December 2017.
O'Brien holds a Bachelor of Science in Combined Sciences (Biology and Chemistry) from Santa Clara University.
Ethan Waxman, Partner within EQT Private Equity's Advisory Team, said: "We undertook an extensive search to find Zeus' next CEO, and Paddy's deep domain knowledge and experience make him perfectly suited to lead the company through this next phase of growth. We look forward to partnering with Paddy as we make significant investments in increased capacity, process improvement, and product innovation."
"We are thrilled to welcome Paddy as the new CEO of Zeus," said John Groetelaars, Executive Chairman at Zeus. "He has deep insights and a keen understanding of the interventional markets targeted by Zeus' customers. His extensive experience and proven track record make him the ideal leader to steer Zeus through this exciting chapter of growth and advancement."
About Zeus
Zeus, headquartered in Orangeburg, South Carolina, is the world's leading polymer extrusion and catheter design manufacturer. With over 55 years of experience in medical, aerospace, energy, automotive, fiber optics, and other leading industries, Zeus' mission is to provide solutions, enable innovation, and enhance lives. The company employs over 2,400 people worldwide with facilities in Aiken, Columbia, Gaston, and Orangeburg, South Carolina; Branchburg, New Jersey; Chattanooga, Tennessee; San Jose, California; Arden Hills, Minnesota; and Letterkenny, Ireland. For more information, visit www.zeusinc.com.

Photo - https://mma.prnewswire.com/media/2362136/Zeus_Inc_Padraic_Paddy_OBrien.jpg
Logo - https://mma.prnewswire.com/media/2362135/Zeus_Inc_Logo.jpg
FONTE Zeus Company, LLC
Ausgewählte Hebelprodukte auf Becton, Dickinson
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Becton, Dickinson
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Becton, Dickinson Aktie News
Becton, Dickinson Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Becton, Dickinson nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.05.19 | Becton, DickinsonCo (BD) Overweight | Barclays Capital | |
| 07.12.18 | Becton, DickinsonCo (BD) Buy | Deutsche Bank AG | |
| 16.10.18 | Becton, DickinsonCo (BD) Equal Weight | Barclays Capital | |
| 09.03.18 | Becton, DickinsonCo (BD) Market Perform | BMO Capital Markets | |
| 29.12.17 | Becton, DickinsonCo (BD) Buy | Deutsche Bank AG |